The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until September, 2020.
Protein Qspec: An Improved Method for Rapid Characterization of Protein Aggregates in Biologic Drugs for Increased Quality and SafetySBC: OPTOFLUIDICS, INC. Topic: 90201
Optofluidics will develop Protein Qspec, a new particle analysis QC instrument designed to characterize protein aggregates in biologic drugs. The primary concern for this class of therapeutics is that they can elicit an immune response from patients who develop anti-drug antibodies which can eliminate the therapeutic benefit. The presence of particulate matter, in these therapeutics (e.g. shed gla ...SBIR Phase I 2016 Department of CommerceNational Institute of Standards and Technology